JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Ascorbate Preferentially Stimulates Gallium-67 Uptake in Glioblastoma Cells

  • 0Department of Radiation Oncology, University of Iowa; Iowa City, IA, USA.
Journal of Nuclear Medicine & Radiation Therapy +

|

August 9, 2024

|

August 9, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Pharmacological ascorbate increases gallium uptake in glioblastoma cells, not normal cells, by affecting iron metabolism and transferrin receptor expression. This finding may impact gallium-based tumor imaging strategies.

Area Of Science

  • Biomedical imaging
  • Cancer therapy
  • Cellular metabolism

Background

  • Gallium mimics iron and enters cells via transferrin receptors.
  • Gallium isotopes (Ga-67, Ga-68) are used for tumor and inflammation imaging.
  • Pharmacological ascorbate is an experimental glioblastoma therapy targeting iron metabolism.

Purpose Of The Study

  • To investigate if pharmacological ascorbate affects gallium uptake in glioblastoma cells.
  • To determine if this effect is specific to cancer cells.

Main Methods

  • Patient-derived glioblastoma cells and normal human astrocytes were used.
  • Cells were co-incubated with Ga-67 in the presence or absence of pharmacological ascorbate.
  • Gallium uptake was measured.

Main Results

  • Glioblastoma cells exhibited higher basal gallium uptake than normal astrocytes.
  • Pharmacological ascorbate significantly increased gallium uptake in glioblastoma cells.
  • Ascorbate did not alter gallium uptake in normal astrocytes.
  • The effect appears linked to increased transferrin receptor expression and iron metabolism.

Conclusions

  • Pharmacological ascorbate enhances gallium uptake in glioblastoma cells, potentially via transferrin receptor modulation.
  • This interaction with iron metabolism warrants further investigation for clinical applications in gallium-based imaging.

Keywords: